Skip to content
DefDex

Federal award

NOVARTIS PHARMACEUTICALS CORPORATION

HT001426PE027

Contract

Obligated and Ceiling

Obligated (net)
$578,754.32
Ceiling (potential value, not spending)
$578,754.32
Current value
$578,754.32
Gross positive obligations
$578,754.32

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
NOVARTIS PHARMACEUTICALS CORPORATION · NG61ZA8TADW3
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
NOVARTIS SANIERUNGSSTIFTUNG · YE3YG1FDWMC5
Awarding agency
Department of War · sub-agency 97DH · office HT0014
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
PIID
HT001426PE027
Award type code
B
Actions
1 · Jan 12, 2026 to Jan 12, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
Jan 12, 2026FY20260—$578,754.32
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.